Upcoming Live Webinar Top ↑ | ||
Coming soon |
Connect 2 Science Top ↑ | ||
Stay connected with our 5-part webinar series on vaccine development research | ||
On-demand | Learn about our solutions for accelerating vaccine development – from Gene Synthesis to Vaccine Expression and Purification. |
SARS-CoV-2Top ↑ | ||
Importance of RT-PCR based COVID-19 testing | Speaker | |
On-demand | Learn more about Thermo Fisher Scientific's affordable and accurate diagnostic solution to enable India’s clinical and public health laboratories to quickly diagnose COVID-19. | |
Science against SARS-CoV-2 Global Virtual Event | Speaker | |
On-demand | Launching June 23rd, the event series will kick off with presentations from key thought leaders from prestigious universities and institutions around the globe. Speakers will share findings, insights and new research techniques that are fueling the efforts in the battle to Eclipse SARS-CoV-2. Over the course of the series, hear from your fellow scientist on the latest achievements and advances in key SARS-CoV-2 research areas | |
Emerging SARS-CoV-2 Mutations webinar available on-demand | ||
On-demand | Emerging SARS CoV-2 Mutations: Impact on Thermo Fisher Assay performance webinar is now available on-demand. | |
Advanced enzymes to facilitate SARS-CoV-2 research | Speaker | |
On-demand | Learn about major technologies used for Sars-Cov-2 research. Understand important features and key considerations of DNA polymerase and reverse transcriptase used for Sars-Cov-2 research. | Li Lavelle Sr.Product Manager Reverse Transcription |
Targeted profiling of critically ill SARS-CoV-2 subjects: from transcriptome to proteome | Speaker | |
On-demand | SARS-CoV-2 continues to spread rapidly with critically ill patients admitted to the intensive care unit (ICU), where the mortality rate is reported to be 31-40%. This webinar will present multiple SARS-CoV-2 investigations to elucidate pathophysiology of subjects suspected of being infected with SARS-CoV-2 and admitted to the ICU using standardized hospital screening methodologies. | Douglas D. Fraser Professor and Clinician Scientist, Western University |
COVID-19 Serology Assays and Cell Therapy Strategies | ||
On-demand | COVID-19 is a highly pathogenic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). A panel of experts were assembled to discuss a variety of current strategies for both serological testing and cell therapies to combat tissue damage caused by COVID-19. | |
Harnessing the Power of Protein Expression Systems in Vaccine Development | ||
On-demand | In just a few months COVID-19 has risen from a regional crisis to a global threat, and drug makers are now scrambling to develop vaccines aimed at thwarting a pandemic. | |
Advanced NGS solutions for SARS-CoV-2 monitoring and insights | ||
On-demand | Next-generation sequencing (NGS) is the primary technology used to identify genomic targets for vaccine development, detect emerging viral strains and monitor transmission patterns. Enhanced options for NGS on Illumina systems from the Invitrogen Collibri portfolio of library prep technology now make it possible to identify multiple potentially pathogenic strains of a disease and understand the rate of evolution quickly, with improved precision. |
PCR Top ↑ | ||
Looking beyond PCR: isothermal amplification | Speaker | |
On-demand | Discover why more researchers are using a next generation enzyme, EquiPhi29 DNA Polymerase, to obtain uniform DNA amplification by MDA. Also learn about the utility of LAMP for molecular diagnostic assay development. | Agne Alminaite, Ph.D. Product Manager, Custom Molecular Biology Products Management Group, Thermo Fisher Scientific Remigijus Skirgaila, Ph.D. Lead R&D Manager, NGS Library Preparation and Protein In Vitro Evolution Group, Thermo Fisher Scientific |
Driving lab efficiency with PCR power | ||
On-demand | In this webinar, we will cover time-saving tips to help increase your PCR productivity. We will address common PCR pitfalls that can be avoided with innovations in enzymes, instruments, and plastics. We will also discuss PCR tools that are available to researchers who wish to push PCR boundaries to overcome research limitation. | |
Molecular diagnostic webinar | ||
On-demand | Overcoming the challenges of accuracy and detection in molecular assays |
Cell BiologyTop ↑ | ||
Introduction to Cell Culture Basics: Detection and Prevention of Cell Culture Contamination | ||
On-demand | Cell culture is one of the major tools used in cellular and molecular biology, providing excellent model systems for studying the normal physiology and biochemistry of cells. Contamination of cell cultures is easily the most common problem encountered in cell culture laboratories. Successful cell culture depends heavily on keeping the cells free from contamination by microorganisms such as bacteria, fungi, and viruses. During this webinar, we will introduce the aseptic technique, which is designed to provide a barrier between the microorganisms in the environment and the sterile cell culture, as well as provide guidelines on the selection of cell culture products to significantly reduce your prep time, lab missteps and the risk of contamination. | |
Gibco Cell Culture Hero webinar | Speaker | |
On-demand | From Protein Structures to Drug Discovery: Novel therapeutic opportunities. Learning Objectives:
| Amal Hassan Ali. Postdoctoral researcher The Institute of Medical Physics and Biophysics, Charité - Universitätsmedizin Berlin |
Gibco cell culture heroes | ||
On-demand | Gibco Cell Culture Heroes spotlights PhD and postdoc researchers across the globe with the primary focus of science communication by telling the story of their research through global webinars. |
Cell and Gene Therapy Top ↑ | ||
Speeding Up Your Cell Therapy Workflow: Next-Generation Immunoassays | ||
On-demand | Discuss the key points to note regarding cell therapy and demonstrate the use of next-generation immunoassays to speed up your workflow. | |
Innovations in immunotherapies webinars | ||
On-demand | From discovery to commercialisation, accelerating your pursuit of better therapeutic outcomes | |
Regulatory FAQs for raw and starting materials | ||
On-demand | In this on-demand webinar, we aim to debunk popular myths, provide practical guidance based upon long experience in the field, and clarify key regulatory considerations and requirements across the cell and gene therapy raw and starting materials area. | |
CAR-T generation for identity, purity and potency assay testing | ||
On-demand | This webinar flows details optimized methods of CAR-T Cell characterization that may be used in pre-clinical and clinical CAR-T manufacturing, following proper validation and regulatory approval. |
Protein ExpressionTop ↑ | ||
Fast and reliable Gene Synthesis for optimized protein expression | Speaker | |
On-demand | Gene Synthesis ensures fast access to nearly any DNA sequence, regardless of its origin or complexity. Its reliability, flexibility and fast turnaround time offer a clear advantage over traditional cloning methods. In this webinar we will show you the easiest and most convenient way to get your desired DNA sequence. We will walk you through the design and ordering process, and illustrate the benefits of gene optimization to achieve maximum expression in your final host. | Claudia Chiocchini Staff Scientist in R&D, Thermo Fisher Scientific |
ExpiSf expression system: a chemically defined baculovirus-based expression system for enhanced protein and virus production in Sf9 cells | Speaker | |
On-demand | Understand how a baculovirus expression vector system can be used for expression of recombinant proteins, virus-like particles, and Adeno-associated virus. | Kenneth Thompson, Ph.D. R&D Manager, Cell Biology, Thermo Fisher Scientific |
Exploring the Immune System | ||
On-demand | Using fundamental protein methods to unravel complex biology | |
2020 Thermo Fisher Scientific Protein Expression User Group Meeting | Speaker | |
On-demand | Part I: | Dr. Jay Yang Market Development Manager, Synthetic Biology and Licensing and Commercial Supplies, Thermo Fisher Scientific Dr. Roland Leathers Senior Strategic Alliances Manager, Cell Biology, Thermo Fisher Scientific |
Protein AnalysisTop ↑ | ||
A novel method for quantitative western blotting that eliminates errors from the use of housekeeping proteins | ||
On-demand | Learning Objectives:
| |
Investigating the AKT-mTOR pathway with targeted mass spectrometry applications | ||
On-demand | This webinar describes targeted mass spectrometry (MS)-based approaches and the various strategies designed to reduce sample complexity through improved sample preparation and enrichment, providing guidance towards targeted MS-assay development, including discussion of antibody verification using immunoprecipitation (IP) coupled with MS analysis. | |
Strategies for isolation of plasma membrane proteins | ||
On-demand | This webinar will focus on robust and optimized techniques for extraction, isolation and enrichment of cell surface proteins, including stable and functional G protein-coupled receptors (GPCRs). | |
Western blotting | Speaker | |
On-demand | Watch our learning series includes poster presentations, on-demand webinars (lectures) to receive firsthand knowledge of the latest technologies for protein gel electrophoresis and western blotting. | Alok Tomar, PhD Product Manager, Protein and Cell Analysis, Thermo Fisher Scientific |
Stem CellsTop ↑ | ||
The use of 3D models in hepatic biology | ||
On-demand | In this webinar, we showcase different approaches to 3D hepatic biology research and how to transition into 3D using different liver cell/tissue types. | |
3-D organoid models for differentiation of PSC-derived dopaminergic neurons | ||
On-demand | This webinar introduced how our R&D team produced 3D midbrain organoids with functional DA neurons with reduced time and effort, as well as the solutions we have on characterization with more accessible and higher-throughput 3-D assays | |
Disease Modeling Webinar Series | ||
On-demand | Advances in stem cell and organoid strategies for disease modeling | |
Cell-based Assays to Functionally Characterize Immunotherapy and the Immune Response to Viral Infection | Speaker | |
On-demand | In this seminar a variety of techniques for immune cell isolation, expansion, and characterization will be demonstrated in cell-based immunotherapy and virology models using powerful cytometric instrumentation. | Chris Langsdorf Staff Scientist, Thermo Fisher Scientific |
Cell Analysis Top ↑ | ||
Advances in techniques and practices for immunology | Speaker | |
On-demand | Whether you want to review the basics, gain more in-depth knowledge, or discover the latest research tools. This Immunology at work virtual symposium contains rich and reliable technical content designed for new and experienced life scientists alike exploring the field of immunology. | |
Key Features of Immune Cells During SARS-CoV2 Infection | Speaker | |
On-demand | In this webinar, Sara describes the abnormally increased levels of cytokines in plasma from samples infected by SARS-CoV-2, and how flow cytometry has helped her investigate the immune system and cells producing cytokines in samples affected by coronavirus | Sara De Biasi Assistant Professor, General Pathology and Immunology, School of Medicine, University of Modena and Reggio Emilia, Modena - Italy and ISAC Marylou Ingram Scholar |
Single-cell analyses of checkpoint-inhibition-induced myocarditis: implications into mechanisms of severe immune-related adverse events | Speaker | |
On-demand | Learn how Dr Justin Balko, Assoc Professor, Vanderbilt University, Department of Medicine, utilized flow cytometry to study immune checkpoint inhibitors as possible treatments in myocarditis associated with cancer. | Dr Justin Balko Assoc Professor, Vanderbilt University |
Learn how flow cytometry streamlines and enhances the CRISPR gene editing workflow | Speaker | |
On-demand | The advent of CRISPR has radically changed the face and pace of biological research and has unlocked unprecedented potential in the study of functional genomics, target identification, and gene therapy. Using flow cytometry in the gene editing workflow can both expedite and augment the process, while enabling a more in-depth and meaningful analysis of engineered cells. | Natasha Jacobsen Technical Sales Specialist for Flow Cytometry Instruments at Thermo Fisher Scientific |
Introducing flow cytometry-assisted antimicrobial susceptibility testing (FAST) | Speaker | |
On-demand | Learn how Dr. Tim Inglis, a clinical microbiologist at the University of Western Australia in Perth, leveraged the speed, accuracy, and broad drug/bug applicability of the Invitrogen Attune NxT Flow Cytometer to get same-day susceptibility results when combined with machine learning-based data analysis. | Dr. Tim Inglis Clinical microbiologist University of Western Australia |
Cell-based Assays to Functionally Characterize Immunotherapy and the Immune Response to Viral Infection | Speaker | |
On-demand | In this seminar a variety of techniques for immune cell isolation, expansion, and characterization will be demonstrated in cell-based immunotherapy and virology models using powerful cytometric instrumentation. | Chris Langsdorf Staff Scientist, Thermo Fisher Scientific |
Oncology Top ↑ | ||
OncomineWorld | ||
On-demand | Hear from leading NGS users on topics such as comprehensive genomic profiling (CGP), the future of precision oncology biomarkers testing in the routine clinical space, personal experiences with different NGS products and solutions, and much more! | |
Advancing translational genomics webinars | ||
On-demand | Our range of Oncomine Solutions cover the widest spectrum of panel sizes and application, offering end-to-end clinical research-grade workflows that address specific challenges when implementing NGS for oncology research. We understand that NGS application and lab needs are different and a one-size-fits-all approach is not suitable. |
Synthetic BiologyTop ↑ | ||
Directed Evolution – shrinking the haystack with tailor-made synthetic DNA | Speaker | |
On-demand | Directed evolution is an effective strategy to optimize the properties of proteins for specific requirements, either for industrial, therapeutics or research applications. As the theoretical diversity in this strategy likely excels screening capability, it is important to shrink this diversity to a manageable, but meaningful size. In this webinar, we will discuss ways to accomplish this task along with important considerations when selecting your directed evolution methods. | Dr. Tobias Santl, PhD Formulation Manufacturing Manager Gene Evolution Library Group |
Avoiding hurdles in molecular assay development | ||
On-demand | This webinar will demonstrate how small changes to assay components (such as enzyme selection) can overcome many of these hurdles during development and significantly impact the overall quality and accuracy of an assay. The presentation will cover specific cases related to SARS-CoV-2 detection and highlight quality and manufacturing considerations crucial to developing a molecular assay for any target. | |
Complete workflow solution from gene-to-protein | ||
On-demand | Reliable expression of recombinant proteins in human, CHO, or insect cells is essential for many aspects of biomedical research and drug development, but is often hampered by low expression yields that limit subsequent structural and functional analyses. The full portfolio of Thermo Fisher Scientific, from GeneArt gene synthesis to optimized eukaryotic/mammalian expression systems, offers researchers the unique opportunity to perfect their gene expression results. | |
Concept-to-Commercialization: Thermo Fisher's unique approach to rapidly advancing your antibody and protein therapeutics | ||
On-demand | Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. The ability to swiftly develop novel therapies often depends on cost-effective candidate screening enabled by technology innovations and process improvements that optimize and expedite the journey from original idea to commercial-scale production. | |
Complete workflow solution from gene-to-protein | Speaker | |
On-demand | Discuss highly advanced expresion systems with optimized genes for protein production | Dr. Stephan Fath Manager, Protein Service Group, Biosciences Division, Regensburg, Germany Thermo Fisher Scientific |
A workflow for knock-in genome editing: simplified | ||
On-demand | This webinar highlights recent advancements in gene editing tools, including application data, that demonstrate the power and ease of a new platform to design genome editing experiments and how innovative donor DNA strategies can be combined with next-generation CRISPR-Cas9 tools and TAL effector nucleases. | |
Tools and methods for CRISPR-Cas9 screening for functional genomics and drug discovery | ||
On-demand | This webinar features the advent and power of CRISPR-Cas9 technology as a powerful tool for single-gene studies as well as high-throughput screening applications. A recent case study was presented to showcase how a screen with LentiArray™ gRNA reagents has enabled long-term assays for phenotypic screening and led to a potential human cancer therapeutic. |
qPCR Top ↑ | ||
qPCR Technical Seminar Series (VIC) | Speaker | |
On-demand | Basics of qPCR Data analysis and microRNA High-throughput solutions for gene expression | David Rayner, PhD Application Specialist Life Sciences Thermo Fisher Scientific |
qPCR Technical Seminar Series (NZ) | Speaker | |
On-demand | Basics of qPCR qPCR applications Guidelines for data analysis & publication | Nicola Dryden
Application Specialist (NZ) Life Sciences Thermo Fisher Scientific |
Top ↑ | |
HIDU Session 1 – Streamlining Workflows (110 min) | |
On-demand | In this session, speakers from PathWest, Queensland Health Forensics and Scientific Services, Flinders University, and Thermo Fisher Scientific discuss VeriFiler Plus, PrepFiler, Touch DNA profiling, and automation in HID. |
HIDU Session 2 – MPS Validation (50 min) | |
On-demand | Speakers from Queensland Health Forensics and Scientific Services, Flinders University and Thermo Fisher Scientific discuss the use of MPS as a powerful validation tool in HID. |
HIDU Session 3 – RapidHIT Speaker Forum (60 min) | |
On-demand | In the final session of HIDU 2021, speakers from Victorian Institute of Forensic Medicine and Thermo Fisher Scientific discuss the use of the RapidHIT instrument for fast DNA profiling. |
Next Gen Sequencing Top ↑ | ||
Role of Next Gen Sequencing in SARS CoV2 Outbreak Management | Speaker | |
On-demand | This webinar brings together scientific experts from multiple fields to present their current knowledge and the future perspectives on SARS-CoV-2 pathogen-host biology, and approaches to monitor the virus spread and implication of Next Generation Technology in this outbreak Management including vaccine research. | Dr. Varsha Potdar Scientist, National Institute of Virology, India Dr. Chaitanya Joshi Director, Gujarat Biotech Research Institute, India Dr. Yvonne Lin Product Manager Clinical Sequencing Divisio |
Concordance study between ReproSeq and Veriseq system preimplantation genetic testing of aneuploidy | Speaker | |
On-demand | The vast majority of preimplantation genetic testing for aneuploidy (PGT-A) is performed using one of two NGS-based platforms, the VeriSeq-PGS platform from Illumina or the Ion ReproSeq-PGS platform from Thermo Fisher Scientific. However, there are few head-to-head data available comparing the two assays. Join us for this webinar, where Dr. Andrea will demonstrate how their team assessed the performance of these two platforms when selecting the assay that best suited the needs of their lab. | Dr Andrea Tzu- Hsuan Chuang Lab Manager Stork Fertility Centre |
View more webinars
For Research Use Only. Not for use in diagnostic procedures.
© 2023 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified.